Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance

GUO Leilei; XU Yurui; ZHANG Lei; DONG Yiwen; LIN Shuting; NING Xinghai; LIU Xiaoxuan

doi:10.11665/j.issn.1000-5048.20180502

Journal of China Pharmaceutical University > 2018 > 49(5): 521-527. > DOI: 10.11665/j.issn.1000-5048.20180502

GUO Leilei, XU Yurui, ZHANG Lei, DONG Yiwen, LIN Shuting, NING Xinghai, LIU Xiaoxuan. Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance[J]. Journal of China Pharmaceutical University, 2018, 49(5): 521-527. DOI: 10.11665/j.issn.1000-5048.20180502

Citation:

PDF (1757 KB)

Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance

More Information

Graphical Abstract

Abstract

Abstract

In comparison with the traditional two-dimensional tumor cell culture, the three-dimensional tumor spheroid culture can not only provide with an in vivo-like growth environment for tumor cells, but also maintain maximum cell activities. Therefore, the three-dimensional tumor spheroid culture is widely used in oncology research. In particular, the three-dimensional tumor cells retain the material and structural basis of the microenvironment of tumor in vivo, which is closer to the actual physiological environment, allowing it to be an ideal in vitro model for evaluating the tumor treatment response and drug resistance in tumors. This review summarizes the mechanisms of drug resistance in three-dimensional tumor cells, especially those induced by the morphology and microenvironment of three-dimensional tumor spheres, and puts forward the problems existing in the current three-dimensional tumor cells model, as well as the future development direction.
- tumor spheroid,
- drug resistance,
- microenvironment

FullText(HTML)

References (51)

References

[1]	Liu YH,Zhong JP,Huo MR.Advances in the tumor microenvironment-responsive smart drug delivery nanosystem[J].J China Pharm Univ(中国药科大学学报),2016,47(2):125-133.
[2]	Palma MD,Biziato D,Petrova TV.Microenvironmental regulation of tumour angiogenesis[J].Nat Rev Cancer,2017,17(8):457-474.
[3]	Dai Y, Xu C, Sun X, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment[J].Chem Soc Rev,2017,46(12):3830-3852.
[4]	Thienpont B,Steinbacher J,Zhao H,et al.Tumor hypoxia causes DNA hypermethylation by reducing TET activity[J].Nature,2016,537(7618):63-68.
[5]	Milosevic MF,Fyles AW,Wong R,et al.Interstitial fluid pressure in cervical carcinoma[J].Cancer,2015,82(12):2418-2426.
[6]	Multhaupt HA,Leitinger B,Gullberg D,et al.Extracellular matrix component signaling in cancer[J].Adv Drug Deliv Rev,2016,97:28-40.
[7]	Ravi M,Ramesh A,Pattabhi A.Contributions of 3D cell cultures for cancer research[J].J Cell Physiol,2017,232(10):2679-2697.
[8]	Nath S, Devi GR. Three-dimensional culture systems in cancer research:focus on tumor spheroid model[J].Pharmacol Ther,2016,163:94-108.
[9]	Weiswald LB,Bellet D,Dangles-Marie V.Spherical cancer models in tumor biology[J].Neoplasia,2015,17(1):1-15.
[10]	Huang SL,Zhao L,Guo QL,et al.Advances of Hedgehog pathway in tumor resistance[J].J China Pharm Univ(中国药科大学学报),2016,47(3):259-266.
[11]	Jiguet JC,Baeza-Kallee N,Denicolaï E,et al.Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening[J].Exp Cell Res,2014,321(2):99-108.
[12]	Raghavan S,Ward MR,Rowley KR,et al.Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays[J].Gynecol Oncol,2015,138(1):181-189.
[13]	Minchinton AI,Tannock IF.Drug penetration in solid tumours[J].Nat Rev Cancer,2006,6(8):583-592.
[14]	Li MY,Lyu HX.Construction and application of three-dimensional tumor spheroid[J].Prog Pharm Sci(药学进展),2017,41(4):285-289.
[15]	Benien P, Swami A. 3D tumor models: history, advances and future perspectives[J].Future Oncol,2014,10(7):1311-1327.
[16]	Fennema E,Rivron N,Rouwkema J,et al.Spheroid culture as a tool for creating 3D complex tissues[J].Trends Biotechnol,2013,31(2):108-115.
[17]	Pavan Grandhi TS,Potta T,Nitiyanandan R,et al.Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation[J].Biomaterials,2017,142:171-185.
[18]	Arai K,Itho M,Mizuno A,et al.Development of spheroid based high-throughput screening of cell-cell adhesion inhibitors to reverse acquired multicellular resistance[J].Cancer Res,2014,74(19 Suppl):697.
[19]	Olive PL,Durand RE.Drug and radiation resistance in spheroids:cell contact and kinetics[J].Cancer Metastasis Rev,1994,13(2):121-138.
[20]	Bates RC,Buret A,Helden DFV,et al.Apoptosis induced by inhibition of intercellular contact[J].J Cell Biol,1994,125(2):403-415.
[21]	Wang Y,Huang Y,Xu X,et al.Expression of small glutamine-rich TPR-containing protein A(SGTA)in non-Hodgkin′s lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance(CAM-DR)[J].Leuk Res,2014,38(8):955-963.
[22]	Durand RE, Sutherland RM. Effects of intercellular contact on repair of radiation damage[J].Exp Cell Res,1972,71(1):75-78.
[23]	Westhoff MA,Fulda S.Adhesion-mediated apoptosis resistance in cancer[J].Drug Resist Updat,2009,12(4/5):127-36.
[24]	Bai C, Yang M, Fan Z, et al. Associations of chemo- and radio-resistant phenotypes with the gap junction,adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma[J].J Exp Clin Cancer Res,2015,34:58.
[25]	Croix BS, Flørenes VA, Rak JW, et al. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents[J].Nat.Med,1996,2(11):1204-1210.
[26]	Folkman J,Moscona A.Role of cell shape in growth control[J].Nature,1978,273(5661):345-349.
[27]	Olive PL,Macphail SH.Radiation-induced DNA unwinding is influenced by cell shape and trypsin[J].Radiat Res,1992,130(2):241-248.
[28]	Raz S,Sheban D,Gonen N,et al.Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest[J].Cell Death Dis,2014,5(2):e1067.
[29]	J Å e,Annadurai N,Frydrych I,et al.Peloruside A-induced cell death in hypoxia is p53 dependent in HCT116 colorectal cancer cells[J].J Nat Prod,2018,81(3):634-640.
[30]	Chang L, Liu X, Wang D, et al. Hypoxia-targeted drug Q6 induces G₂-M arrest and apoptosis via poisoning topoisomerase II under hypoxia[J].PLoS One,2015,10(12):e0144506.
[31]	Azad MB,Chen Y,Henson ES,et al.Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3[J].Autophagy,2014,4(2):195-204.
[32]	Li X,Liu X,Xu Y,et al.KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α[J].Int J Oncol,2014,45(4):1507-1514.
[33]	Kim JW, Ho WJ, Wu BM. The role of the 3D environment in hypoxia-induced drug and apoptosis resistance[J].Anticancer Res,2011,31(10):3237-3245.
[34]	Qin Y,Roszik J,Chattopadhyay C,et al.Hypoxia-driven mechanism of vemurafenib resistance in melanoma[J].Mol Cancer Ther,2016,15(10):2442-2454.
[35]	Sonveaux P,Végran F,Schroeder T,et al.Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice[J].J Clin Invest,2008,118(12):3930-3942.
[36]	Spugnini EP, Sonveaux P, Stock C, et al. Proton channels and exchangers in cancer[J].Biochim Biophys Acta,2015,1848(10 Pt B):2715-2726.
[37]	Mehdi D,Wojtkowiak JW,Gillies RJ.pH sensing and regulation in cancer[J].Front Physiol,2013,4(370):370.
[38]	Rauch C.On the relationship between drug′s size,cell membrane mechanical properties and high levels of multi drug resistance:a comparison to published data[J].Eur Biophys J,2009,38(4):537-546.
[39]	Panagiotopoulou V,Richardson G,Jensen OE,et al.On a biophysical and mathematical model of Pgp-mediated multidrug resistance:understanding the “space-time” dimension of MDR[J].Eur Biophys J,2010,39(2):201-211.
[40]	Patel KJ,Trédan O,Tannock IF.Distribution of the anticancer drugs doxorubicin,mitoxantrone and topotecan in tumors and normal tissues[J].Cancer Chemother Pharmacol,2013,72(1):127-138.
[41]	Pan ST,Li ZL,He ZX,et al.Molecular mechanisms for tumour resistance to chemotherapy[J].Clin Exp Pharmacol Physiol,2016,43(8):723-737.
[42]	Luciani F,Spada M,De MA,et al.Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs[J].J Natl Cancer Inst,2004,96(22):1702-1713.
[43]	Pettersson OA,Olsson P,Lindström P,et al.Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids[J].Melanoma Res,1993,3(5):369-376.
[44]	Beaumont KA,Hill DS,Daignault SM,et al.Cell cycle phase-specific drug resistance as an escape mechanism of melanoma cells[J].J Invest Dermatol,2016,136(7):1479-1489.
[45]	Haass NK, Beaumont KA, Hill DS, et al. Real-time cell cycle imaging during melanoma growth,invasion,and drug response[J].Pigment Cell Melanoma Res,2015,27(5):764-776.
[46]	Visconti R,Monica RD,Grieco D.Cell cycle checkpoint in cancer:a therapeutically targetable double-edged sword[J].J Exp Clin Cancer Res,2016,35(1):153.
[47]	Santini MT,Rainaldi G,Indovina PL.Apoptosis,cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids[J].Crit Rev Oncol Hematol,2000,36(2):75-87.
[48]	Berton S, Cusan M, Segatto I, et al. Loss of p27kip1 increases genomic instability and induces radio-resistance in luminal breast cancer cells[J].Sci Rep,2017,7(1):595.
[49]	Fu Z, Wang F, Cai J. Gene expression changes in residual advanced cervical cancer after radiotherapy:indicators of poor prognosis and radioresistance[J]?Med Sci Monit,2015,21:1276-1287.
[50]	Sethi T,Rintoul RC,Moore SM,et al.Extracellular matrix proteins protect small cell lung cancer cells against apoptosis:a mechanism for small cell lung cancer growth and drug resistance in vivo[J].Nat Med,1999,5(6):662-668.
[51]	Zanoni M,Piccinini F,Arienti C,et al.3D tumor spheroid models forin vitrotherapeutic screening:a systematic approach to enhance the biological relevance of data obtained[J].Sci Rep,2016,6:19103.

[1]	SU Haiying, WANG Yukun, LI Weisong, ZHOU Jianping, CHENG Hao. Advances in anti-Alzheimer’s disease nano drug delivery system based on pathogenic mechanism of ferroptosis[J]. Journal of China Pharmaceutical University, 2024, 55(5): 613-623. DOI: 10.11665/j.issn.1000-5048.2024040702
[2]	CHANG Yuan, MAGETA Mageta Samwel, LI Nibowen, TANG Yingqi, LI Huangjuan, QIAN Chenggen. Research advances in modulating microglia for intervening in Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(5): 603-612. DOI: 10.11665/j.issn.1000-5048.2024030201
[3]	LAN Aili, LIU Gang, WU Chaoran, LIAO Hong. Research progress of integrated stress response in central nervous system diseases[J]. Journal of China Pharmaceutical University, 2024, 55(2): 194-201. DOI: 10.11665/j.issn.1000-5048.2023112302
[4]	ZHAO Mengqi, LIAO Hong. Researches progress of the relationship between neuro-inflammation and cognitive function[J]. Journal of China Pharmaceutical University, 2019, 50(4): 497-504. DOI: 10.11665/j.issn.1000-5048.20190416
[5]	CHEN Suting, CHEN Song, GAO Xiangdong. Construction, expression, purification and neuroprotective activity of TAT-FGF21 fusion protein[J]. Journal of China Pharmaceutical University, 2018, 49(4): 496-501. DOI: 10.11665/j.issn.1000-5048.20180417
[6]	YU Haiyang, CHEN Song, XU Zheng, GAO Xiangdong, YAO Wenbing. Protective effect of fibroin peptides on Aβ_25-35-induced injury in SH-SY5Y cells and its mechanism[J]. Journal of China Pharmaceutical University, 2017, 48(5): 609-613. DOI: 10.11665/j.issn.1000-5048.20170517
[7]	YAN Ruizuo, GUO Baojian, YU Pei, ZHANG Zaijun. Effect of rasagiline on neuroprotection and behavior improvement in MPTP-induced acute mouse model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2016, 47(5): 603-608. DOI: 10.11665/j.issn.1000-5048.20160517
[8]	NI Jie, LIU Gaoxiang, LIAO Hong. Expression of p75 neurotrophin receptor and its role in drug development[J]. Journal of China Pharmaceutical University, 2015, 46(6): 751-756. DOI: 10.11665/j.issn.1000-5048.20150620
[9]	CHEN Mengfei, FANG Lei, CHEN Li. Design, synthesis and anti-Alzheimer′s disease activity of 5-akylaminomethyl substituted carbazole derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(6): 647-652. DOI: 10.11665/j.issn.1000-5048.20150602
[10]	SHEN Kai, KOU Junping, YU Boyang. Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(5): 532-540. DOI: 10.11665/j.issn.1000-5048.20150503

Cited By

Cited by

Periodical cited type(6)

1.	段盼盼，赵丽娟，吴姿，杨子妮，王燕清. 直接进样气相色谱法用于助悬剂中乙二醇二甘醇和三甘醇残留量测定方法研究. 实用医技杂志. 2024(04): 241-244 .
2.	孔祥祥，李建兵，陈东，孙晨磊，王婷，孙云，臧金秋，宋蕾，梁野. 气相色谱法测定聚乙二醇200中乙二醇、二甘醇、三甘醇和四甘醇含量. 质量安全与检验检测. 2024(03): 6-9 .
3.	黄丽梅，曹玉，戴震，仝立卿，张珂. GC法测定对乙酰氨基酚口服液体制剂辅料中乙二醇及二甘醇残留量. 云南化工. 2024(08): 124-127 .
4.	杨军林，陈明学，田栋伟，尹艳艳，张二康，尤小龙，张健，程平言. GC-MS/MS法直接测定酱香型白酒中二乙二醇的含量. 食品科技. 2022(06): 303-309 .
5.	郜淑晓，祝颂，赵恂，袁耀佐，宋敏，杭太俊，陆宇婷. 聚氧乙烯中乙二醇和二甘醇残留的HPLC和GC测定法比较研究. 药物分析杂志. 2020(10): 1820-1827 .
6.	田嘉铭，于小红，王银月，王旭，王治宝，王金，卢金铭. 气相色谱法测定糖平煎复方中苍术酮含量. 神经药理学报. 2020(05): 14-17 .

Other cited types(1)

Get Citation

PDF

XML

Article views (1078) PDF downloads (1726) Cited by(7)

Turn off MathJax

Article Contents

Abstract

References

Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(1)

Catalog

Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance

Abstract

References

Related Articles

Cited by

Periodical cited type(6)

Other cited types(1)

Catalog

Export File

Citation

Format

Content